Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - December 2025

Traditional market access practices are being transformed by an increasingly rocky landscape of rebate, discount, and direct-distribution practices, but artificial intelligence may clear the pathways to profitability.

The Key to Connecting with Patients: Pharma's Market Access Transformation

How pharma can productively coexist with PBMs—and still lower drug costs faster.

Working with the Middle

As safety data grows in scale and complexity, AI-powered pharmacovigilance is emerging as a strategic imperative—helping drugmakers improve detection, reduce risk, and strengthen commercial performance.

The Next Era of Drug Safety is in Intelligent Action

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

A $1.5 million investment in its facilities located near Los Angeles International Airport strengthens DHL’s cold chain capacity, supporting pharmaceutical and healthcare shipments while advancing the company’s long-term health logistics strategy for the Americas.

DHL Global Forwarding Expands LAX Cold Storage 

Videos

Bill Roth, general manager and managing partner of IntegriChain’s consulting business, previews his new six-part series by outlining how rising payer fragmentation, divergent cash and insurance models, and supply-chain constraints are reshaping brand strategy. 

Trade & Channel Strategies 2025: Why Pharma Is Entering a Multi-Payer, Multi-Pricing, Multi-Channel Era

Podcasts

In today’s Pharma Pulse, the Senate advances legislation to block "biotechnology companies of concern," clinical research ties COVID-19 to REM-dominant sleep apnea, and a new analysis reveals an affordability breaking point for employer-sponsored health insurance.

Pharma Pulse: Navigating the Biosecure Act, Post-Viral Sleep Phenotypes, and Rising Insurance Costs

The CDMO’s latest GMP-qualified line strengthens sterile manufacturing scalability.

Alcami Brings Third Sterile Fill-Finish Line Online. Expanding Clinical-to-Commercial Capacity

A professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business.

In a discussion on global trade disruption, Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business, explains why pharmaceutical manufacturers must move beyond broad assumptions about tariffs and instead assess trade risk at the individual product level. 

Trade & Channel Strategies 2025: Why Product-Level Strategy Matters More Than Ever

In today’s Pharma Pulse, House Republicans block a critical insurance subsidy extension, as new research highlights the oncology benefits of GLP-1s.

Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s

The acquisition strengthens CEVA’s global project logistics footprint, adding heavy-lift expertise, specialized engineering talent, and integrated solutions across key regions.

CEVA Logistics Expands End-to-End Capabilities With Acquisition of Project Logistics Specialist Fagioli

In a discussion on emerging channel strategies, Bill Roth, general manager and managing partner of IntegriChain’s consulting business, explains why DTP models must extend beyond simple cash-pay offerings—highlighting how packaging innovation, insurance-flow backups, and improved patient compliance could unlock new revenue, streamline access, and better reflect clinical outcomes.

Trade & Channel Strategies 2025: Rethinking Direct-to-Patient

In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and physician well-being reshape the future of clinical care.

Featured Content

Pharmaceutical Commerce - December 2025

The Key to Connecting with Patients: Pharma's Market Access Transformation

Working with the Middle

The Next Era of Drug Safety is in Intelligent Action